New Lifetime High Reached By Parexel International (PRXL)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Parexel International ( PRXL) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Parexel International as such a stock due to the following factors:

  • PRXL has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $32.9 million.
  • PRXL has traded 2,475 shares today.
  • PRXL is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in PRXL with the Ticky from Trade-Ideas. See the FREE profile for PRXL NOW at Trade-Ideas

More details on PRXL:

PAREXEL International Corporation is a biopharmaceutical outsourcing services company. PRXL has a PE ratio of 25. Currently there are 5 analysts that rate Parexel International a buy, no analysts rate it a sell, and 7 rate it a hold.

The average volume for Parexel International has been 454,100 shares per day over the past 30 days. Parexel International has a market cap of $3.8 billion and is part of the health care sector and health services industry. The stock has a beta of 0.50 and a short float of 7.8% with 8.28 days to cover. Shares are up 27.1% year-to-date as of the close of trading on Friday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

With Hurricane Harvey, We Are in the Crosshairs of Volatility: Market Recon

EY's Greene Sees More Med Tech, CRO Deals Ahead

Stocks Lower as Crude Oil Slides on Supply Concerns

Stock Futures Narrowly Mixed as Oil Plunges to Fresh 2017 Low